Tohoku U Spinoff Targeting Pharma Industry with SRM-MS Assays for ADMET Research | GenomeWeb

By Adam Bonislawski

Having recently inked deals with two contract research organizations, Japanese proteomics firm Proteomedix Frontiers is looking to apply its targeted mass spectrometry platform to drug discovery and development.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.